ABCELLERA BIOLOGICS INC's ticker is ABCL and the CUSIP is 00288U106. A total of 180 filers reported holding ABCELLERA BIOLOGICS INC in Q1 2023. The put-call ratio across all filers is 0.20 and the average weighting 0.7%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $169,469 | -76.6% | 36,841 | -67.1% | 0.00% | – |
| Q2 2023 | $723,391 | -33.0% | 111,980 | -21.8% | 0.00% | – |
| Q1 2023 | $1,079,245 | +26.3% | 143,136 | +69.7% | 0.00% | – |
| Q4 2022 | $854,263 | +12.4% | 84,330 | +9.7% | 0.00% | – |
| Q3 2022 | $760,000 | -2.3% | 76,889 | +5.2% | 0.00% | – |
| Q2 2022 | $778,000 | +26.5% | 73,091 | +15.9% | 0.00% | – |
| Q1 2022 | $615,000 | -53.4% | 63,051 | -31.6% | 0.00% | – |
| Q4 2021 | $1,319,000 | -55.0% | 92,183 | -37.0% | 0.00% | -100.0% |
| Q3 2021 | $2,934,000 | +162.9% | 146,391 | +188.6% | 0.00% | – |
| Q2 2021 | $1,116,000 | -56.6% | 50,722 | -33.0% | 0.00% | -100.0% |
| Q1 2021 | $2,569,000 | +32012.5% | 75,672 | +37736.0% | 0.00% | – |
| Q4 2020 | $8,000 | – | 200 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Founders Fund VII Management, LLC | 3,773,530 | $37,320,000 | 92.58% |
| Gruss & Co., LLC | 308,570 | $3,052,000 | 26.27% |
| Founders Fund Growth Management, LLC | 407,017 | $4,025,000 | 11.55% |
| Belmont Capital, LLC | 510,000 | $5,044,000 | 5.95% |
| HARVARD MANAGEMENT CO INC | 4,105,095 | $40,599,000 | 5.05% |
| GUARDIAN CAPITAL ADVISORS LP | 3,736,414 | $40,129,000 | 5.01% |
| Intellectus Partners, LLC | 1,091,505 | $10,795,000 | 3.84% |
| ArchPoint Investors | 617,213 | $6,104,000 | 2.49% |
| BRANDYWINE MANAGERS, LLC | 56,976 | $563,000 | 1.85% |
| Casdin Capital, LLC | 1,650,000 | $16,319,000 | 1.07% |